Related Experiment Videos
Insulin resistance in chronic hepatitis C
G Yazicioglu1, F Isitan, H Altunbas
1Akdeniz University School of Medicine, Antalya, Turkey.
International Journal of Clinical Practice
|December 21, 2004
Summary
Insulin resistance (IR) is common in chronic hepatitis C patients, often preceding diabetes. This study found IR in these patients, suggesting it stems from the hepatitis C virus itself, not liver injury.
Area of Science:
- Hepatology
- Endocrinology
- Virology
Background:
- Insulin resistance (IR), glucose intolerance, and diabetes mellitus are frequently observed in cirrhosis.
- The precise mechanisms linking these conditions to hepatitis C virus (HCV) and liver injury remain unclear.
- IR may manifest early and progress to clinical diabetes mellitus over time.
Purpose of the Study:
- To investigate the presence and extent of insulin resistance in patients with chronic hepatitis C.
- To determine if IR in these patients is related to the degree of liver injury or specific viral factors.
Main Methods:
- The study enrolled 15 patients with chronic hepatitis C and 9 healthy controls.
- Insulin resistance was assessed using the gold-standard euglycaemic hyperinsulinemic clamp technique.
- Peripheral glucose utilization rate (M value) was calculated to quantify insulin sensitivity.
Main Results:
- Patients with chronic hepatitis C exhibited significantly lower M values compared to healthy controls (3.7+/-1 vs. 5.1+/-1; p = 0.004), confirming insulin resistance.
- No significant correlation was found between the M value and liver enzymes (ALT, AST) or hepatic activity index.
- This indicates that IR is not directly caused by the extent of liver damage in chronic hepatitis C.
Conclusions:
- Insulin resistance is a significant finding in patients with chronic hepatitis C.
- The results suggest that IR in this population is associated with factors inherent to the hepatitis C virus, rather than the severity of liver injury.
- Further research is warranted to elucidate the specific viral components responsible for IR in chronic hepatitis C.